Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Nature Medicine2017Vol. 23(10), pp. 1167–1175
Citations Over TimeTop 10% of 2017 papers
Daniel Shao-Weng Tan, Fui Teen Chong, Hui Sun Leong, Shen Yon Toh, Dawn Pingxi Lau, Xue Lin Kwang, Xiaoqian Zhang, Gopinath M. Sundaram, Gek San Tan, Mei Mei Chang, Boon Tin Chua, Wan‐Teck Lim, Eng Huat Tan, Mei‐Kim Ang, Tony Kiat Hon Lim, Prabha Sampath, Balram Chowbay, Anders J. Skanderup, Ramanuj DasGupta, N. Gopalakrishna Iyer
Related Papers
- → Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib(2006)583 cited
- → Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer(2004)202 cited
- → Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy(2006)37 cited
- → Efficacy of Gefitinib for Elderly Patients with Advanced Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Gene Mutations: A Retrospective Analysis(2010)34 cited
- → Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor(2016)8 cited